secwatch / observer
8-K filed March 25, 2026, 7:59 PM ET ticker BLGO CIK 0000880242
other material confidence high sentiment neutral materiality 0.60

BioLargo enters $10M equity purchase agreement with Clearthink Capital Partners

BIOLARGO, INC.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

BIOLARGO, INC. issued 500,000 shares of common stock to CLEARTHINK CAPITAL PARTNERS, LLC.

Security
common stock
Shares
500,000 shares
Purchaser
CLEARTHINK CAPITAL PARTNERS, LLC
Exact text from the filing
we agreed to issue Clearthink 500,000 shares of our Common Stock (the “Commitment Shares”) upon the execution of the Purchase Agreement.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIOLARGO, INC. entered into Purchase Agreement with CLEARTHINK CAPITAL PARTNERS, LLC valued at up to $10.0 million (effective 2026-03-20).

Action
entry
Agreement
equity purchase
Counterparty
CLEARTHINK CAPITAL PARTNERS, LLC
Value
up to $10.0 million
Effective
2026-03-20
Exact text from the filing
On March 20, 2026, BioLargo, Inc. (the “Company” or “we”) entered into a purchase agreement dated as of March 20, 2026 (the “Purchase Agreement”), and a registration rights agreement dated as of March 20, 2026 (the “Registration Rights Agreement”), with CLEARTHINK CAPITAL PARTNERS, LLC (“Clearthink”), pursuant to which Clearthink has committed to purchase up to $10.0 million of the Company’s common stock
View on SEC.gov

Browse all equity issuances →

BIOLARGO, INC. filing history →

Source: SEC EDGAR
accession 0001437749-26-009813
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.